Abiopharma

Novo estudo da MetLife revela uma "lacuna de confiança" de 72% na capacidade de se recuperar dos reveses da vida

Une nouvelle étude de MetLife révèle un « déficit de confiance » de 72 % quant à la capacité à se remettre des épreuves de la vie

Un nuevo estudio de MetLife revela una “falta de confianza” del 72% en la capacidad para recuperarse de los reveses de la vida

Eine neue Studie von MetLife deckt eine „Vertrauenslücke“ von 72 % hinsichtlich der Fähigkeit auf, Rückschläge im Leben zu überwinden

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Glass House Brands Announces Uplist to NYSE

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms

KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT